September 10, 2025Frontiers in EndocrinologyOpen Access

Comprehensive bioinformatics and in vivo validation reveal key molecular drivers of diabetic nephropathy progression

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Integrative bioinformatics reveals key genes in diabetic nephropathy progression, indicating new therapeutic targets.

Four genes—COL1A2, CD163, FN1, and CCL2—are identified as key drivers of diabetic nephropathy progression, linking immune activation and inflammation.
Analysis of human and mouse samples showed consistent upregulation of these genes, emphasizing their potential as biomarkers for diabetic nephropathy.
The study utilized bioinformatics methods, including gene co-expression analysis and machine learning, to uncover molecular drivers of the disease.
Identified genes may lead to novel insights and strategies for clinical management of diabetic nephropathy and its impact on patients.

Yang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 10, 2025Frontiers in EndocrinologyOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Integrative bioinformatics reveals key genes in diabetic nephropathy progression, indicating new therapeutic targets.

Four genes—COL1A2, CD163, FN1, and CCL2—are identified as key drivers of diabetic nephropathy progression, linking immune activation and inflammation.
Analysis of human and mouse samples showed consistent upregulation of these genes, emphasizing their potential as biomarkers for diabetic nephropathy.
The study utilized bioinformatics methods, including gene co-expression analysis and machine learning, to uncover molecular drivers of the disease.
Identified genes may lead to novel insights and strategies for clinical management of diabetic nephropathy and its impact on patients.

Yang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark